FULGENT GENETICS, INC. Other Current Liabilities
FULGENT GENETICS, INC. (FLGT) had Other Current Liabilities of $0 as of 2024-03-31, per its 10-Q filed 2024-05-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2025-02-28
- 2024-03-31: Other Liabilities, Current $0.00.
- 2023-12-31: Other Liabilities, Current $164.00K.
- 2023-09-30: Other Liabilities, Current $281.00K.
- 2023-06-30: Other Liabilities, Current $362.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $164.00K 10-K · filed 2025-02-28 | |
| 2023-09-30 | $281.00K 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $362.00K 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $3.81M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $5.30M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $13.62M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $661.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.09M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $680.00K 10-K · filed 2023-02-28 | |
| 2021-09-30 | $39.92M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $13.06M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $12.56M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $82.00K 10-K · filed 2022-02-28 | $8.53M 10-Q · filed 2021-05-07 |
| 2016-09-30 | $1.25M 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |